INS and Alzheimer disease: In terms of signaling pathways, and in cases of diabetes, reduced insulin levels and reduced insulin receptor expression are associated with AD and the defective activation of the insulin/IGF-1/PI3K/Akt pathway of intracellular signals, which is a major effector for insulin’s action in the brain [105,184].